COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 2238: Articles 22371-22380  | Next

Anti-SARS-CoV-2 IgM and IgG antibodies in health workers in Sergipe, Brazil
Melo, M. S. d., BORGES, L. P., SOUZA, D. R. V., MARTINS, A. F., NETO, J. M. D. R., RIBEIRO, A. A., SANTOS, A., INVENCAO, G. B. D., MATOS, I. L. S., SANTOS, K. A. D., SOUZA, N. A. A., BORGES, P. C., OLIVEIRA, M. G. B. D.
10.1101/2020.09.24.20200873 — Posted: 2020-09-25
What have we learned about positive changes experienced during COVID-19 lockdown? Evidence of the social patterning of change
Williams, L., Rollins, L., Young, D., Fleming, L., Grealy, M., Janssen, X., Kirk, A., MacDonald, B., Flowers, P.
10.1101/2020.09.24.20200865 — Posted: 2020-09-25
Risk assessment of COVID-19 airborne infection during hybrid learning
Anchordoqui, L. A., Chudnovsky, E. M., Paul, T. C.
10.1101/2020.09.24.20200782 — Posted: 2020-09-25
FeverIQ - A Privacy-Preserving COVID-19 SymptomTracker with 3.6 Million Reports
Ranjan, A., Li, S., Chen, B., Chiu, A., Jagadeesh, K., Liphardt, J.
10.1101/2020.09.23.20200006 — Posted: 2020-09-25
On the Analysis of Mortality Risk Factors for Hospitalized COVID-19 Patients: a Data-driven Study Using the Major Brazilian Database
Souza, F. S. H., Hojo-Souza, N. S., Batista, B. D. d. O., da Silva, C. M., Guidoni, D. L.
10.1101/2020.09.24.20200766 — Posted: 2020-09-25
Identifying gaps in COVID-19 health equity data reporting in Canada using a scorecard approach
Blair, A., Warsame, K., Naik, H., Byrne, W., Parnia, A., Siddiqi, A.
10.1101/2020.09.23.20200147 — Posted: 2020-09-25
Impact of COVID-19 on the mortality rates for the resident population of the Umbria region in Italy
Bietta, C., Morini, M., Kamber Zaidi, A., Cozzolino, F., Dehgani-Mobaraki, P.
10.1101/2020.09.24.20200667 — Posted: 2020-09-25
Quantifying the impact of quarantine duration on COVID-19 transmission
Ashcroft, P., Lehtinen, S., Bonhoeffer, S.
10.1101/2020.09.24.20201061 — Posted: 2020-09-25
Evidence for and level of herd immunity against SARS-CoV-2 infection: the ten-community study
Jeremijenko, A., Chemaitelly, H., Ayoub, H. H., Abdulla, M. A. H., Abou-Samra, A. B., Al Ajmi, J. A. A. A., Al-Ansari, N. A. A., Al Kanaani, Z., Al Khal, A., Al Kuwari, E., Al-Mohammed, A., Al Molawi, N. H. A., Al Naomi, H. M., Butt, A. A., Coyle, P., El Kahlout, R. A., Gillani, I., Kaleeckal, A. H., Masoodi, N. A., Thomas, A. G., Hego, H. N., Latif, A. N., Shaik, R. M., Younes, N. B. M., Abdul Rahim, H. F., Yassine, H. M., Al Kuwari, M. G., Al Romaihi, H. E., Al Thani, S. M., Bertollini, R., Abu-Raddad, L. J.
10.1101/2020.09.24.20200543 — Posted: 2020-09-25 Discussion: Onsite
First phylogenetic analysis of Malian SARS-CoV-2 sequences provide molecular insights into the genomic diversity of the Sahel region
Kouriba, B., Duerr, A., Rehn, A., Sangare, A. K., Traoure, B. Y., Bestehorn-Willmann, M. S., Ouedraogo, J. L., Heitzer, A., Sogodogo, E., Maiga, A., Walter, M. C., Zimmermann, F., Woelfel, R., Antwerpen, M. H.
10.1101/2020.09.23.20165639 — Posted: 2020-09-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).